Liraglutide NEW

Profile:

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, widely recognized for its role in managing type 2 diabetes and obesity. 

Marketed under the brand name Victoza for diabetes and Saxenda for weight loss, liraglutide mimics the action of GLP-1, 

a hormone that stimulates insulin secretion in response to high blood sugar levels. 

This mechanism not only aids in lowering blood glucose but also slows gastric emptying and promotes a feeling of satiety, contributing to weight reduction.

In addition to improving glycemic control in patients with type 2 diabetes, liraglutide has shown cardiovascular benefits by 

reducing the risk of major adverse cardiovascular events such as heart attack, stroke, or death from cardiovascular causes. 

Its administration involves once-daily subcutaneous injection.

It's important to note that while liraglutide offers significant benefits for individuals with type 2 diabetes and those looking to manage their weight effectively; 

it may not be suitable for everyone. Potential side effects include nausea, diarrhea, and pancreatitis among others; 

hence healthcare providers carefully consider patient history before prescribing this medication.

Reference Quality Standards

Appearance: white powder white powder

Purity(HPLC) ≥98.0%

Single impurity≤1.0%

Acetate content 5.0%~12.0

Water content≤10.0%

Peptide content ≥80.0

Endotoxin≤5EU/mg

Product Forms: Nasal Spray, Injectable Solution, Oral Capsules/Tablets, Solution/Drops

Related peptides: Semaglutide, Dulaglutide, Albiglutide, Exenatide, etc.

Payment method: T/T in advance, Paypal, Western Union, L/C, etc.

Shipping ways: Courier, Air, Sea, Road

Storage Condition: Dry, dark, and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).